APO Research
Talk to an analyst

APO RESEARCH · REPORT

Infectious Bursal Disease Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Research

Infectious Bursal Disease Vaccine Industry Research Report 2026

1 January 2026121 pages

Choose your research edition.

Industry ResearchInfectious Bursal Disease Vaccine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Infectious Bursal Disease Vaccine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Infectious Bursal Disease Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Infectious Bursal Disease Vaccine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Infectious Bursal Disease Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Infectious Bursal Disease Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Infectious Bursal Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Infectious Bursal Disease Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Infectious Bursal Disease Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Infectious Bursal Disease Vaccine include Shandong Lvdu Biological Technology Co., Ltd., Ruipu Biopharmaceutical Co., Ltd., Qingdao Yibang Biological Engineering Co., Ltd., Plyco Bioengineering Co., Ltd., Merck, Harbin Pharmaceutical Group Biological Vaccine Co., Ltd., Zoetis, Elanco and Ceva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Infectious Bursal Disease Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Infectious Bursal Disease Vaccine Market by Company

Shandong Lvdu Biological Technology Co., Ltd.

Ruipu Biopharmaceutical Co., Ltd.

Qingdao Yibang Biological Engineering Co., Ltd.

Plyco Bioengineering Co., Ltd.

Merck

Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.

Zoetis

Elanco

Ceva

Boehringer Ingelheim

Infectious Bursal Disease Vaccine Segment by Type

Live

Inactivated

Infectious Bursal Disease Vaccine Segment by Application

Veterinary Pharmacy

Online Sale

Others

Infectious Bursal Disease Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Infectious Bursal Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Infectious Bursal Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Infectious Bursal Disease Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Infectious Bursal Disease Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Infectious Bursal Disease Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Infectious Bursal Disease Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Infectious Bursal Disease Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Infectious Bursal Disease Vaccine Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Infectious Bursal Disease Vaccine Sales Market Share by Manufacturers (2021-2026) Table 8. Global Infectious Bursal Disease Vaccine Revenue of Manufacturers (2021-2026) Table 9. Global Infectious Bursal Disease Vaccine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Infectious Bursal Disease Vaccine Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Infectious Bursal Disease Vaccine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Infectious Bursal Disease Vaccine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Infectious Bursal Disease Vaccine, Product Type & Application Table 14. Global Infectious Bursal Disease Vaccine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Infectious Bursal Disease Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Shandong Lvdu Biological Technology Co., Ltd. Company Information Table 19. Shandong Lvdu Biological Technology Co., Ltd. Business Overview Table 20. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio Table 22. Shandong Lvdu Biological Technology Co., Ltd. Recent Developments Table 23. Ruipu Biopharmaceutical Co., Ltd. Company Information Table 24. Ruipu Biopharmaceutical Co., Ltd. Business Overview Table 25. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio Table 27. Ruipu Biopharmaceutical Co., Ltd. Recent Developments Table 28. Qingdao Yibang Biological Engineering Co., Ltd. Company Information Table 29. Qingdao Yibang Biological Engineering Co., Ltd. Business Overview Table 30. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio Table 32. Qingdao Yibang Biological Engineering Co., Ltd. Recent Developments Table 33. Plyco Bioengineering Co., Ltd. Company Information Table 34. Plyco Bioengineering Co., Ltd. Business Overview Table 35. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio Table 37. Plyco Bioengineering Co., Ltd. Recent Developments Table 38. Merck Company Information Table 39. Merck Business Overview Table 40. Merck Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Merck Infectious Bursal Disease Vaccine Product Portfolio Table 42. Merck Recent Developments Table 43. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information Table 44. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Business Overview Table 45. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio Table 47. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments Table 48. Zoetis Company Information Table 49. Zoetis Business Overview Table 50. Zoetis Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Zoetis Infectious Bursal Disease Vaccine Product Portfolio Table 52. Zoetis Recent Developments Table 53. Elanco Company Information Table 54. Elanco Business Overview Table 55. Elanco Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Elanco Infectious Bursal Disease Vaccine Product Portfolio Table 57. Elanco Recent Developments Table 58. Ceva Company Information Table 59. Ceva Business Overview Table 60. Ceva Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Ceva Infectious Bursal Disease Vaccine Product Portfolio Table 62. Ceva Recent Developments Table 63. Boehringer Ingelheim Company Information Table 64. Boehringer Ingelheim Business Overview Table 65. Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Portfolio Table 67. Boehringer Ingelheim Recent Developments Table 68. Global Infectious Bursal Disease Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 69. Global Infectious Bursal Disease Vaccine Sales by Region (2021-2026) & (K Units) Table 70. Global Infectious Bursal Disease Vaccine Sales Market Share by Region (2021-2026) Table 71. Global Infectious Bursal Disease Vaccine Sales by Region (2027-2032) & (K Units) Table 72. Global Infectious Bursal Disease Vaccine Sales Market Share by Region (2027-2032) Table 73. Global Infectious Bursal Disease Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 74. Global Infectious Bursal Disease Vaccine Revenue Market Share by Region (2021-2026) Table 75. Global Infectious Bursal Disease Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 76. Global Infectious Bursal Disease Vaccine Revenue Market Share by Region (2027-2032) Table 77. North America Infectious Bursal Disease Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. North America Infectious Bursal Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 79. North America Infectious Bursal Disease Vaccine Sales by Country (2027-2032) & (K Units) Table 80. North America Infectious Bursal Disease Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 81. North America Infectious Bursal Disease Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 82. Europe Infectious Bursal Disease Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Europe Infectious Bursal Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 84. Europe Infectious Bursal Disease Vaccine Sales by Country (2027-2032) & (K Units) Table 85. Europe Infectious Bursal Disease Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 86. Europe Infectious Bursal Disease Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 87. Asia Pacific Infectious Bursal Disease Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Asia Pacific Infectious Bursal Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 89. Asia Pacific Infectious Bursal Disease Vaccine Sales by Country (2027-2032) & (K Units) Table 90. Asia Pacific Infectious Bursal Disease Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 91. Asia Pacific Infectious Bursal Disease Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 92. South America Infectious Bursal Disease Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. South America Infectious Bursal Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 94. South America Infectious Bursal Disease Vaccine Sales by Country (2027-2032) & (K Units) Table 95. South America Infectious Bursal Disease Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 96. South America Infectious Bursal Disease Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 97. Middle East and Africa Infectious Bursal Disease Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Middle East and Africa Infectious Bursal Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 99. Middle East and Africa Infectious Bursal Disease Vaccine Sales by Country (2027-2032) & (K Units) Table 100. Middle East and Africa Infectious Bursal Disease Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 101. Middle East and Africa Infectious Bursal Disease Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 102. Global Infectious Bursal Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 103. Global Infectious Bursal Disease Vaccine Sales by Type (2027-2032) & (K Units) Table 104. Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2021-2026) Table 105. Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2027-2032) Table 106. Global Infectious Bursal Disease Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 107. Global Infectious Bursal Disease Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 108. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2021-2026) Table 109. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2027-2032) Table 110. Global Infectious Bursal Disease Vaccine Price by Type (2021-2026) & (US$/Unit) Table 111. Global Infectious Bursal Disease Vaccine Price by Type (2027-2032) & (US$/Unit) Table 112. Global Infectious Bursal Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 113. Global Infectious Bursal Disease Vaccine Sales by Application (2027-2032) & (K Units) Table 114. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2021-2026) Table 115. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2027-2032) Table 116. Global Infectious Bursal Disease Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 117. Global Infectious Bursal Disease Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 118. Global Infectious Bursal Disease Vaccine Revenue Market Share by Application (2021-2026) Table 119. Global Infectious Bursal Disease Vaccine Revenue Market Share by Application (2027-2032) Table 120. Global Infectious Bursal Disease Vaccine Price by Application (2021-2026) & (US$/Unit) Table 121. Global Infectious Bursal Disease Vaccine Price by Application (2027-2032) & (US$/Unit) Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Infectious Bursal Disease Vaccine Distributors List Table 125. Infectious Bursal Disease Vaccine Customers List Table 126. Infectious Bursal Disease Vaccine Industry Trends Table 127. Infectious Bursal Disease Vaccine Industry Drivers Table 128. Infectious Bursal Disease Vaccine Industry Restraints Table 129. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Infectious Bursal Disease Vaccine Product Image Figure 5. Global Infectious Bursal Disease Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Infectious Bursal Disease Vaccine Market Size (2021-2032) & (US$ Million) Figure 7. Global Infectious Bursal Disease Vaccine Sales (2021-2032) & (K Units) Figure 8. Global Infectious Bursal Disease Vaccine Average Price (US$/Unit) & (2021-2032) Figure 9. Live Product Image Figure 10. Inactivated Product Image Figure 11. Veterinary Pharmacy Product Image Figure 12. Online Sale Product Image Figure 13. Others Product Image Figure 14. Global Infectious Bursal Disease Vaccine Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Infectious Bursal Disease Vaccine, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Infectious Bursal Disease Vaccine Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Infectious Bursal Disease Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Infectious Bursal Disease Vaccine Sales by Region in 2025 Figure 20. Global Infectious Bursal Disease Vaccine Revenue by Region in 2025 Figure 21. North America Infectious Bursal Disease Vaccine Market Size by Country in 2025 Figure 22. North America Infectious Bursal Disease Vaccine Sales Market Share by Country (2021-2032) Figure 23. North America Infectious Bursal Disease Vaccine Revenue Market Share by Country (2021-2032) Figure 24. United States Infectious Bursal Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Infectious Bursal Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Infectious Bursal Disease Vaccine Market Size by Country in 2025 Figure 27. Europe Infectious Bursal Disease Vaccine Sales Market Share by Country (2021-2032) Figure 28. Europe Infectious Bursal Disease Vaccine Revenue Market Share by Country (2021-2032) Figure 29. Germany Infectious Bursal Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Infectious Bursal Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Infectious Bursal Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Infectious Bursal Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Netherlands Infectious Bursal Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Asia Pacific Infectious Bursal Disease Vaccine Market Size by Country in 2025 Figure 35. Asia Pacific Infectious Bursal Disease Vaccine Sales Market Share by Country (2021-2032) Figure 36. Asia Pacific Infectious Bursal Disease Vaccine Revenue Market Share by Country (2021-2032) Figure 37. China Infectious Bursal Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Japan Infectious Bursal Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. South Korea Infectious Bursal Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. India Infectious Bursal Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Australia Infectious Bursal Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. China Taiwan Infectious Bursal Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Southeast Asia Infectious Bursal Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Southeast Asia Infectious Bursal Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South America Infectious Bursal Disease Vaccine Market Size by Country in 2025 Figure 46. South America Infectious Bursal Disease Vaccine Sales Market Share by Country (2021-2032) Figure 47. South America Infectious Bursal Disease Vaccine Revenue Market Share by Country (2021-2032) Figure 48. Mexico Infectious Bursal Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Brazil Infectious Bursal Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Argentina Infectious Bursal Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Middle East and Africa Infectious Bursal Disease Vaccine Market Size by Country in 2025 Figure 52. Middle East and Africa Infectious Bursal Disease Vaccine Sales Market Share by Country (2021-2032) Figure 53. Middle East and Africa Infectious Bursal Disease Vaccine Revenue Market Share by Country (2021-2032) Figure 54. Turkey Infectious Bursal Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Saudi Arabia Infectious Bursal Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. UAE Infectious Bursal Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2021-2032) Figure 58. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2021-2032) Figure 59. Global Infectious Bursal Disease Vaccine Price (US$/Unit) by Type (2021-2032) Figure 60. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2021-2032) Figure 61. Global Infectious Bursal Disease Vaccine Revenue Market Share by Application (2021-2032) Figure 62. Global Infectious Bursal Disease Vaccine Price (US$/Unit) by Application (2021-2032) Figure 63. Infectious Bursal Disease Vaccine Value Chain Figure 64. Infectious Bursal Disease Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Infectious Bursal Disease Vaccine Industry Opportunities and Challenges

Scope & coverage.

Types
  • Live
  • Inactivated
Applications
  • Veterinary Pharmacy
  • Online Sale
  • Others
Companies covered
  • Shandong Lvdu Biological Technology Co., Ltd.
  • Ruipu Biopharmaceutical Co., Ltd.
  • Qingdao Yibang Biological Engineering Co., Ltd.
  • Plyco Bioengineering Co., Ltd.
  • Merck
  • Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
  • Zoetis
  • Elanco
  • Ceva
  • Boehringer Ingelheim

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Infectious Bursal Disease Vaccine Market Size (2021-2032)
  4. 2.2.2 Global Infectious Bursal Disease Vaccine Sales (2021-2032)
  5. 2.2.3 Global Infectious Bursal Disease Vaccine Market Average Price (2021-2032)
  6. 2.3 Infectious Bursal Disease Vaccine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Live
  9. 2.3.3 Inactivated
  10. 2.4 Infectious Bursal Disease Vaccine by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Veterinary Pharmacy
  13. 2.4.3 Online Sale
  14. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Infectious Bursal Disease Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Infectious Bursal Disease Vaccine Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Infectious Bursal Disease Vaccine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Infectious Bursal Disease Vaccine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Infectious Bursal Disease Vaccine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Infectious Bursal Disease Vaccine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Infectious Bursal Disease Vaccine, Product Type & Application
  8. 3.8 Global Manufacturers of Infectious Bursal Disease Vaccine, Established Date
  9. 3.9 Global Infectious Bursal Disease Vaccine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Shandong Lvdu Biological Technology Co., Ltd.
  2. 4.1.1 Shandong Lvdu Biological Technology Co., Ltd. Company Information
  3. 4.1.2 Shandong Lvdu Biological Technology Co., Ltd. Business Overview
  4. 4.1.3 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
  6. 4.1.5 Shandong Lvdu Biological Technology Co., Ltd. Recent Developments
  7. 4.2 Ruipu Biopharmaceutical Co., Ltd.
  8. 4.2.1 Ruipu Biopharmaceutical Co., Ltd. Company Information
  9. 4.2.2 Ruipu Biopharmaceutical Co., Ltd. Business Overview
  10. 4.2.3 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
  12. 4.2.5 Ruipu Biopharmaceutical Co., Ltd. Recent Developments
  13. 4.3 Qingdao Yibang Biological Engineering Co., Ltd.
  14. 4.3.1 Qingdao Yibang Biological Engineering Co., Ltd. Company Information
  15. 4.3.2 Qingdao Yibang Biological Engineering Co., Ltd. Business Overview
  16. 4.3.3 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
  18. 4.3.5 Qingdao Yibang Biological Engineering Co., Ltd. Recent Developments
  19. 4.4 Plyco Bioengineering Co., Ltd.
  20. 4.4.1 Plyco Bioengineering Co., Ltd. Company Information
  21. 4.4.2 Plyco Bioengineering Co., Ltd. Business Overview
  22. 4.4.3 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
  24. 4.4.5 Plyco Bioengineering Co., Ltd. Recent Developments
  25. 4.5 Merck
  26. 4.5.1 Merck Company Information
  27. 4.5.2 Merck Business Overview
  28. 4.5.3 Merck Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Merck Infectious Bursal Disease Vaccine Product Portfolio
  30. 4.5.5 Merck Recent Developments
  31. 4.6 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
  32. 4.6.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information
  33. 4.6.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Business Overview
  34. 4.6.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
  36. 4.6.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments
  37. 4.7 Zoetis
  38. 4.7.1 Zoetis Company Information
  39. 4.7.2 Zoetis Business Overview
  40. 4.7.3 Zoetis Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Zoetis Infectious Bursal Disease Vaccine Product Portfolio
  42. 4.7.5 Zoetis Recent Developments
  43. 4.8 Elanco
  44. 4.8.1 Elanco Company Information
  45. 4.8.2 Elanco Business Overview
  46. 4.8.3 Elanco Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Elanco Infectious Bursal Disease Vaccine Product Portfolio
  48. 4.8.5 Elanco Recent Developments
  49. 4.9 Ceva
  50. 4.9.1 Ceva Company Information
  51. 4.9.2 Ceva Business Overview
  52. 4.9.3 Ceva Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Ceva Infectious Bursal Disease Vaccine Product Portfolio
  54. 4.9.5 Ceva Recent Developments
  55. 4.10 Boehringer Ingelheim
  56. 4.10.1 Boehringer Ingelheim Company Information
  57. 4.10.2 Boehringer Ingelheim Business Overview
  58. 4.10.3 Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Portfolio
  60. 4.10.5 Boehringer Ingelheim Recent Developments
5 Global Infectious Bursal Disease Vaccine Market Scenario by Region
  1. 5.1 Global Infectious Bursal Disease Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Infectious Bursal Disease Vaccine Sales by Region: 2021-2032
  3. 5.2.1 Global Infectious Bursal Disease Vaccine Sales by Region: 2021-2026
  4. 5.2.2 Global Infectious Bursal Disease Vaccine Sales by Region: 2027-2032
  5. 5.3 Global Infectious Bursal Disease Vaccine Revenue by Region: 2021-2032
  6. 5.3.1 Global Infectious Bursal Disease Vaccine Revenue by Region: 2021-2026
  7. 5.3.2 Global Infectious Bursal Disease Vaccine Revenue by Region: 2027-2032
  8. 5.4 North America Infectious Bursal Disease Vaccine Market Facts & Figures by Country
  9. 5.4.1 North America Infectious Bursal Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Infectious Bursal Disease Vaccine Sales by Country (2021-2032)
  11. 5.4.3 North America Infectious Bursal Disease Vaccine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Infectious Bursal Disease Vaccine Market Facts & Figures by Country
  15. 5.5.1 Europe Infectious Bursal Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Infectious Bursal Disease Vaccine Sales by Country (2021-2032)
  17. 5.5.3 Europe Infectious Bursal Disease Vaccine Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Infectious Bursal Disease Vaccine Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Infectious Bursal Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Infectious Bursal Disease Vaccine Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Infectious Bursal Disease Vaccine Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Infectious Bursal Disease Vaccine Market Facts & Figures by Country
  35. 5.7.1 South America Infectious Bursal Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Infectious Bursal Disease Vaccine Sales by Country (2021-2032)
  37. 5.7.3 South America Infectious Bursal Disease Vaccine Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Infectious Bursal Disease Vaccine Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Infectious Bursal Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Infectious Bursal Disease Vaccine Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Infectious Bursal Disease Vaccine Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Infectious Bursal Disease Vaccine Sales by Type (2021-2032)
  2. 6.1.1 Global Infectious Bursal Disease Vaccine Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2021-2032)
  4. 6.2 Global Infectious Bursal Disease Vaccine Revenue by Type (2021-2032)
  5. 6.2.1 Global Infectious Bursal Disease Vaccine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Infectious Bursal Disease Vaccine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Infectious Bursal Disease Vaccine Sales by Application (2021-2032)
  2. 7.1.1 Global Infectious Bursal Disease Vaccine Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2021-2032)
  4. 7.2 Global Infectious Bursal Disease Vaccine Revenue by Application (2021-2032)
  5. 7.2.1 Global Infectious Bursal Disease Vaccine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Infectious Bursal Disease Vaccine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Infectious Bursal Disease Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Infectious Bursal Disease Vaccine Value Chain Analysis
  2. 8.1.1 Infectious Bursal Disease Vaccine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Infectious Bursal Disease Vaccine Production Mode & Process
  5. 8.2 Infectious Bursal Disease Vaccine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Infectious Bursal Disease Vaccine Distributors
  8. 8.2.3 Infectious Bursal Disease Vaccine Customers
9 Global Infectious Bursal Disease Vaccine Analyzing Market Dynamics
  1. 9.1 Infectious Bursal Disease Vaccine Industry Trends
  2. 9.2 Infectious Bursal Disease Vaccine Industry Drivers
  3. 9.3 Infectious Bursal Disease Vaccine Industry Opportunities and Challenges
  4. 9.4 Infectious Bursal Disease Vaccine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst